Jochen Maas
Impact in
- Hematology top 5%
- Multiple Myeloma Research and Treatments
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
Papers in
-
- Pharmacogenetics and Drug Metabolism 3
-
- Drug Solubulity and Delivery Systems 1
- Co-authors
- J I Johnson (1 shared paper)Antonia T. Destree (1 shared paper)Edward A. Sausville (1 shared paper)Christine S. Pien (1 shared paper)Julian Adams (1 shared paper)Peter J. Elliott (1 shared paper)Douglas D. Lazarus (1 shared paper)Vito J. Palombella (1 shared paper)
- Journals
- Regulatory Toxicology and Pharmacology (2 papers)Clinical Pharmacology & Therapeutics (1 paper)European Journal of Pharmaceutics and Biopharmaceutics (1 paper)Journal of drug targeting (1 paper)EMBO Molecular Medicine (1 paper)
- Partner nations
- GermanyFranceSwitzerland
In The Last Decade
Jochen Maas
15 papers receiving 1.7k citations
Jochen Maas's Hit Papers
Peers
Comparison fields: 5 of 95
- Hematology 235
- Pharmacology 135
- Molecular Biology 667
- Drug Discovery 3
- Cancer Research 107
Countries citing papers authored by Jochen Maas
This map shows the geographic impact of Jochen Maas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jochen Maas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jochen Maas more than expected).
Fields of papers citing papers by Jochen Maas
This network shows the impact of papers produced by Jochen Maas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jochen Maas. The network helps show where Jochen Maas may publish in the future.
Co-authors
The 25 scholars most cited alongside Jochen Maas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Proteasome inhibitors: a novel class of potent and effective antitumor agents. Hit paper breakdown → | 1999 | 1250 |
| 2 | 2003 | 227 | |
| 3 | 1997 | 97 | |
| 4 | 2006 | 54 | |
| 5 | 1998 | 31 | |
| 6 | 2002 | 27 | |
| 7 | 2000 | 23 | |
| 8 | 2006 | 18 | |
| 9 | 2000 | 14 | |
| 10 | 2002 | 13 | |
| 11 | 2019 | 9 | |
| 12 | 2024 | 2 | |
| 13 | 2002 | 1 | |
| 14 | 2010 | 1 | |
| 15 | 2018 | 1 |
About Jochen Maas
Jochen Maas is a scholar working on Pharmacology, Pharmaceutical Science, Radiation, Health Informatics and Radiological and Ultrasound Technology, having authored 15 papers that have together received 1.8k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (3 papers), Radiopharmaceutical Chemistry and Applications (2 papers), Radioactive Decay and Measurement Techniques (2 papers), Drug Solubulity and Delivery Systems (1 paper), Artificial Intelligence in Healthcare and Education (1 paper), Biotechnology and Related Fields (1 paper), Nanoparticle-Based Drug Delivery (1 paper) and Public-Private Partnership Projects (1 paper). The work is most often cited by research in Hematology (235 citations), Pharmacology (135 citations), Molecular Biology (667 citations), Drug Discovery (3 citations) and Cancer Research (107 citations). Jochen Maas has collaborated with scholars based in Germany, France and Switzerland. Frequent co-authors include J I Johnson, Antonia T. Destree, Edward A. Sausville, Christine S. Pien, Julian Adams, Peter J. Elliott, Douglas D. Lazarus, Vito J. Palombella, Andreas W. Herling and Karl Seeger. Their work appears in journals such as Regulatory Toxicology and Pharmacology, Clinical Pharmacology & Therapeutics, European Journal of Pharmaceutics and Biopharmaceutics, Journal of drug targeting and EMBO Molecular Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.